Registry for pulmonary hypertension in lung cancer patients
Giessen Pulmonary Hypertension in Lung Cancer Registry
This study looks at how common pulmonary hypertension is in lung cancer patients and what it means for their health.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Giessen Academic / other |
| Locations | 1 site (Giessen, Hesse) |
| Trial ID | NCT04467333 on ClinicalTrials.gov |
What this trial studies
This observational study aims to investigate the occurrence and implications of pulmonary hypertension in patients diagnosed with lung cancer. Data will be collected from all lung cancer patients treated at the University Hospital Giessen, focusing on identifying pulmonary hypertension as a potential comorbidity. The study will analyze existing treatment data without any interventions, serving as a prospective registry for these patients. The findings may provide insights into the relationship between lung cancer and pulmonary hypertension.
Who should consider this trial
Good fit: Ideal candidates for this study are patients diagnosed with lung cancer at the University of Giessen Lung Cancer Center.
Not a fit: Patients with lung cancer who are not treated at the University of Giessen will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of pulmonary hypertension in lung cancer patients, potentially leading to improved management strategies.
How similar studies have performed: While the specific approach of this registry may be novel, similar studies have indicated the importance of understanding comorbidities in cancer patients.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient with lung cancer at the University of Giessen lung Cancer Center. Exclusion Criteria: \-
Where this trial is running
Giessen, Hesse
- University hospital Giessen — Giessen, Hesse, Germany (Recruiting)
Study contacts
- Principal investigator: Bastian Eul, MD — JLU Giessen
- Study coordinator: Bastian Eul, MD
- Email: bastian.eul@innere.med.uni-giessen.de
- Phone: (+49) 0641/985-42371
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.